Meningococcal ACWY Vaccine Group
Meningococcal Vaccine Group Evaluation and Forecasting Rules
General Rules for Meningococcal
General rules are not series-specific; general rules apply to the entire vaccine group.
Meningococcal Vaccines
CVX Code | Name | Absolute Minimum Age |
|---|---|---|
114 | Meningococcal MCV4P (Menactra) | 9 months - 4 days |
136 | Meningococcal MCV4O (Menveo) | 2 months - 4 days |
| 32 | Meningococcal MPSV4 (Menomune) | 2 years - 4 days |
108 | Meningococcal, unspecified formulation | 2 years - 4 days4 |
| 147 | Meningococcal MCV4, unspecified formulation | 9 months - 4 days4 |
| 203 | Meningococcal MenACWY-TT (MenQuadfi) | 2 years - 4 days |
Combination Vaccines that Include Meningococcal
No combination vaccines exist, at this time, that include meningococcal and count toward completion of the meningococcal series.
Immunization Series and Selection Rules
Immunization Series: MCV4 2-dose Series
This is a 2-dose series, except when the Meningococcal ACWY Vaccine Group MCV4 2-Dose Series Exception Rule applies. This series, however, will never have a forecast of "Complete"; see the Meningococcal ACWY Vaccine Group Series Completion Special Rule.
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
|---|---|---|---|---|---|---|---|
1 | MCV4 2-dose | 10 years | 11 years | 11 years | 13 years + 4 weeks | 114, 136, 108, 147, 32, 203 | N/A |
2 | MCV4 2-dose | 16 years - 4 days | 16 years | 16 years | 17 years + 4 weeks | 114, 136, 108, 147, 32, 203 | N/A |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Minimum Recommended Interval | Latest Recommended Interval (less than) |
|---|---|---|---|---|---|
Dose 1 to 2 | MCV4 2-dose | 52 days | 56 days | 56 days2 | 6 years + 4 weeks |